MedTrace Logo

HeRO Graft Compared to Permanent Catheters for End Stage Renal Disease (ESRD) Patients Receiving Hemodialysis

NCT01343251 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 33

Last updated 2017-09-08

Study results available
· View outcomes & findings →

Summary

The main objective of this research study was to compare the following outcomes between patients with a Hemodialysis Reliable Outflow (HeRO) Graft and patients with a cuffed catheter for dialysis access over one year: quality of life and incidence of bacteremia, vascular interventions, hospitalizations, and death.

Conditions

  • End Stage Renal Disease (ESRD)

Sponsors & Collaborators

  • CryoLife, Inc.

    collaborator INDUSTRY

  • Merit Medical Systems, Inc.

    lead INDUSTRY

Principal Investigators

  • Robert Provenzano, MD · St. Clair Specialty Physicians

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01343251 on ClinicalTrials.gov